eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetesLei Gao, Ayako Makino, Qiuyu Zheng et al.|Diabetologia|2024Cited by 6
Abstract 14798: NAMPT Inhibition Restores Coronary Microvascular Dysfunction in DiabetesFrancisco J Ramirez, Ayako Makino, Lei Gao et al.|Circulation|2023Cited by 0
Vascular Rarefaction as a Cause of Diabetic Coronary Microvascular DiseaseF. Daniel Ramirez, Ayako Makino, Lei Gao et al.|Physiology|2025Cited by 0